T-cell acute lymphoblastic leukemia pediatric · 5 regimens
Cost vs Efficacy
| Regimen | Biomarker | Cost/cycle ↓ | Cycle | PFS ↕ | OS ↕ | Est. cycles | Course cost ↕ | Evidence |
|---|---|---|---|---|---|---|---|---|
Doxorubicin, Methotrexate, Pegaspargase, Vincristine, Methylprednisolone Variant #01 | — | R 1 950 | 28d | — | — | — | — | — |
Daunorubicin, L-Asparaginase, Vincristine, Dexamethasone N/A - intrathecal component | — | R 81 | 28d | — | — | — | — | — |
DOLP N/A - intrathecal component | — | R 71 | 42d | — | — | — | — | — |
Daunorubicin, Pegaspargase, Vincristine, Dexamethasone N/A - intrathecal component | — | R 67 | 28d | — | — | — | — | — |
Daunorubicin, Pegaspargase, Vincristine, Prednisone N/A - intrathecal component | — | R 66 | 28d | — | — | — | — | — |
5 of 5 regimens shown